statnews.com·May 7, 2026
The FDA is reconsidering a rare cancer treatment that it previously rejected, amid ongoing concerns about political interference in drug reviews and the emergence of AI-driven virtual cancer care solutions. Additionally, the Trump administration is promoting secret drug pricing deals, though their claimed savings lack independent verification.
A key insight for you is the emergence of AI oncology startups, such as the virtual AI cancer clinic from Color Health, which aims to revolutionize cancer care by making it virtual. This development indicates a growing trend towards integrating AI and digital platforms in oncology, highlighting potential investment opportunities and areas for collaboration in digital health and telemedicine.